# Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males

> **NCT06542237** · PHASE1,PHASE2 · RECRUITING · sponsor: **YourChoice Therapeutics, Inc.** · enrollment: 88 (estimated)

## Conditions studied

- Male Contraception

## Interventions

- **DRUG:** YCT-529

## Key facts

- **NCT ID:** NCT06542237
- **Lead sponsor:** YourChoice Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-11
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06542237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06542237, "Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06542237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*